Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.
Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer.
Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.
Despite today’s headlines, there’s no good evidence linking air pollution with breast cancer.
Combining new ways to measure molecules could lead to the most accurate picture of tumours ever created. We explore the science behind the approach.
Our new report looks at what GPs know about offering tamoxifen and aspirin to lower the risk of, or prevent, certain cancers.
We’re announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge
Why is the shape of a cancer cell so important for predicting how the disease will behave? Our scientists may have an answer.
Meet our new leaders, who are spearheading research to tackle some of the biggest questions we need to answer to help more people survive cancer.
Our scientists are looking at immune cells in breast cancer in greater detail than ever before.